Related Experiment Video
Updated: Aug 26, 2026

Analyzing Murine Schwann Cell Development Along Growing Axons
Published on: November 21, 2012
Nerve growth factor and brain-derived neurotrophic factor in human paediatric hemimegalencephaly
A Antonelli1, A Chiaretti, T Amendola
1Institute of Neurobiology and Molecular Medicine, Neurobiology Section CNR, Rome, Italy.
Insights
Paediatric hemimegalencephaly (HME) involves brain enlargement and seizures. Studies show elevated nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in HME infants, suggesting a role in this rare neurological disorder.
Area of Science:
- Neuroscience
- Developmental Biology
- Pediatric Neurology
Background:
- Paediatric hemimegalencephaly (HME) is a congenital brain malformation.
- HME is characterized by unilateral cerebral hemisphere enlargement, intractable seizures, and intellectual disability.
- Neuropathological findings include cortical thickening and disrupted lamination.
Purpose of the Study:
- To investigate the role of neurotrophic factors in paediatric hemimegalencephaly (HME).
- To examine the levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in HME patients.
- To explore potential associations between neurotrophic factors and HME pathogenesis.
Main Methods:
- Analysis of cerebral tissue samples from infants diagnosed with HME.
- Measurement of NGF and BDNF levels using biochemical assays.
- Assessment of NGF-receptor expression and choline acetyltransferase (ChAT) immunoreactivity in cortical and vascular tissues.
Main Results:
- Elevated cerebral tissue levels of NGF and BDNF were observed in infants with HME.
- Abnormal NGF-receptor expression was noted in the subcortical blood vessels of HME patients.
- A significant reduction in cortical choline acetyltransferase (ChAT) immunoreactivity suggests dysregulated NGF activity.
Conclusions:
- Increased NGF and BDNF levels may play a role in the pathogenesis of paediatric hemimegalencephaly (HME).
- Aberrant NGF signaling, indicated by receptor expression and ChAT levels, could contribute to HME development.
- These findings highlight potential therapeutic targets for HME, focusing on neurotrophic factor pathways.
Abstract:
Paediatric hemimegalencephaly (HME) is a congenital central nervous system (CNS) disorder, characterized by monolateral cerebral hemisphere enlargement, intractable seizures starting in the post-neonatal period, and mental retardation associated with neuropathological anomalies (mainly cortical thickness and lack of lamination). Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are two neurotrophic factors produced in the mammalian CNS that are involved in the survival, development, and function of a variety of brain cells. In the present study, we found increased cerebral tissue levels of NGF and BDNF in 4 infants with HME; these changes appear to be also associated with abnormal NGF-receptor expression in subcortical blood vessels. Moreover, the marked reduction of cortical choline acetyltransferase immunoreactivity is strongly suggestive of a dysregulation in the NGF differentiative activity in this site that could lead to the pathogenesis of HME.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

